Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
- Citation:
- J Gastrointest Cancer vol 38 (1) 10-4
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA25224, CA37404, CA60276
- Corr. Author:
- Authors:
- Steven R Alberts Vera J Suman Henry C Pitot John K Camoriano Joseph Rubin
- Networks:
- Study
- NCCTG-964251
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Antineoplastic Agents, Carcinoma, Hepatocellular, Female, Humans, Kaplan-Meier Estimate, Liver Neoplasms, Male, Middle Aged, Pyrrolidinones, Treatment Outcome